Ovarian small cell carcinoma of hypercalcemic type–evidence of germline origin and smarca4 gene inactivation. A pilot study
J Kupryjańczyk, A Dansonka-Mieszkowska… - Polish Journal of …, 2013 - termedia.pl
Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4
gene inactivation. a pilot study Journals Advances in Dermatology and Allergology/Postępy …
gene inactivation. a pilot study Journals Advances in Dermatology and Allergology/Postępy …
PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations
IK Kolasa, A Rembiszewska, A Janiec-Jankowska… - Gynecologic …, 2006 - Elsevier
OBJECTIVE.: We aimed to evaluate frequency of PTEN mutation, LOH and expression in
ovarian tumors. In search for a molecular pathway, we confronted PTEN gene mutations with …
ovarian tumors. In search for a molecular pathway, we confronted PTEN gene mutations with …
PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors
B Konopka, A Janiec–Jankowska, E Kwiatkowska… - Human pathology, 2011 - Elsevier
Alterations of the PIK3CA gene occur in endometrial carcinomas, but their role in the
carcinogenesis of those malignancies is still poorly understood. In this study, PIK3CA …
carcinogenesis of those malignancies is still poorly understood. In this study, PIK3CA …
Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias
B Konopka, Z Paszko, A Janiec-Jankowska, M Goluda - Cancer Letters, 2002 - Elsevier
The quality and frequency of mutations in PTEN gene were assessed in 59 carcinomas and
6 hyperplasias of the endometrium in women. Screening for mutations was done in all exons …
6 hyperplasias of the endometrium in women. Screening for mutations was done in all exons …
Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
B Konopka, A Janiec-Jankowska, D Czapczak… - Journal of cancer …, 2007 - Springer
Purpose The present study aims to assess the incidence of microsatellite instability (MSI)
and mutations in the PTEN and beta-catenin (CTNNB1) genes in endometrial carcinomas …
and mutations in the PTEN and beta-catenin (CTNNB1) genes in endometrial carcinomas …
TP53 mutations in endometrial cancers
A Janiec-Jankowska, B Konopka, C Goluda… - International Journal of …, 2010 - ijgc.bmj.com
Objective: The PTEN and TP53 genes participate in the carcinogenesis of many
malignancies, but the role of both genes in endometrial carcinogenesis is not fully …
malignancies, but the role of both genes in endometrial carcinogenesis is not fully …
The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
B Konopka, A Janiec-Jankowska, Z Paszko… - Journal of cancer …, 2004 - Springer
Purpose To evaluate the frequency of ERBB2, INT2 and CMYC oncogene amplifications
and their coexistence with PTEN gene mutations in endometrial carcinomas. Methods In 54 …
and their coexistence with PTEN gene mutations in endometrial carcinomas. Methods In 54 …
Low frequency of the CHEK2* 1100delC mutation among breast cancer probands from three regions of Poland.
E Kwiatkowska, E Skasko, A Niwinska… - Neoplasma, 2006 - europepmc.org
The 1100delC germline mutation of the CHEK2 gene appears to contribute significantly to
the overall breast cancer incidence in some West and North European countries, but seems …
the overall breast cancer incidence in some West and North European countries, but seems …
[PDF][PDF] Changes in BRCA1 gene in patients with familial breast cancer in the Warsawregion of Poland
Z Paszko, E Skasko, A Wiśniewska… - … Journal of Oncology, 2002 - journals.viamedica.pl
SpoÊród przesz∏ o 500 kobiet chorych na raka sutka, leczonych w Centrum Onkologii w
Warszawie, wyselekcjonowano 52 probantki, które by∏ y obarczone rodzinnym …
Warszawie, wyselekcjonowano 52 probantki, które by∏ y obarczone rodzinnym …
No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival
LE Sucheston-Campbell, R Cannioto, AI Clay… - … , biomarkers & prevention, 2017 - AACR
Background: The precise mechanism by which the immune system is adversely affected in
cancer patients remains poorly understood, but the accumulation of immunosuppressive …
cancer patients remains poorly understood, but the accumulation of immunosuppressive …